ArticleJournal of medical microbiology2025
The ability of ozone to counteract multidrug-resistant bacteria if used as an adjunct therapy: a bioinformatic modelling.
Article in Journal of medical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- SIOOTAntibiotics (Basel, Switzerland) · 2026Article
- Medical ozone: mechanisms, biological effects and clinical evidence-a narrative review.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multidrug-resistant (MDR) bacteria pose a growing threat to global health, prompting exploration of alternative therapies. This study uses bioinformatic modelling to assess ozone therapy as an adjunct treatment, analysing both linear and non-linear (chaotic) frameworks. Results suggest that ozone exerts bactericidal effects and modulates immune responses, partly through the production of 4-hydroxynonenal. Simulations indicate that ozone-induced adaptive chaos may enhance immune resilience and accelerate bacterial clearance compared to antibiotics alone. However, the findings are theoretical, and the short half-life of ozone limits direct impact, emphasizing the need for experimental validation. Ozone therapy shows promise, but its role in adaptive chaos requires further study to determine its clinical viability, despite a large number of reports showing an undisputable action of medical ozone against MDR bacteria.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.